Landiolol - CAS 133242-30-5
Catalog number: 133242-30-5
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C25H39N3O8
Molecular Weight:
509.60
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Landiolol is an ultra-short-acting Beta 1 adrenergic receptor antagonist using for managing supraventricular tachyarrhythmias in sepsis. It is also used as an anti-arrhythmic agent.
Purity:
> 95%
Appearance:
Powder
Synonyms:
Landiolol; ONO-1101; ONO 1101; ONO1101; UNII-62NWQ924LH; [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate;144481-98-1(hydrochloride)
Solubility:
Soluble in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
antiarrhythmic agent
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
InChIKey:
WMDSZGFJQKSLLH-RBBKRZOGSA-N
InChI:
1S/C25H39N3O8/c1-25(2)35-18-22(36-25)17-34-23(30)8-5-19-3-6-21(7-4-19)33-16-20(29)15-26-9-10-27-24(31)28-11-13-32-14-12-28/h3-4,6-7,20,22,26,29H,5,8-18H2,1-2H3,(H,27,31)/t20-,22+/m0/s1
Canonical SMILES:
C1(OC[C@H](O1)COC(CCc1ccc(OC[C@H](CNCCNC(N2CCOCC2)=O)O)cc1)=O)(C)C
Current Developer:
Originator Ono Pharmaceutical
1.[A Case of Undiagnosed Extra-adrenal Pheochromocytoma in an Adult Patient with Single Ventricle Circulation after the Bidirectional Glenn Operation].
Kohno M, Nagamine Y, Goto T. Masui. 2015 Sep;64(9):985-8.
We experienced a case of undiagnosed extra-adrenal pheochromocytoma in an adult patient with single ventricle circulation after the bidirectional Glenn operation. A 32-year-old woman was scheduled for open abdominal surgery for incidental retroperitoneal tumor. She had undergone the bidirectional Glenn operation for complex congenital heart disease consisting of double outlet right ventricle, ventricular septal defect, and pulmonary artery stenosis. She had not undergone the Fontan operation because of insufficient development of pulmonary circulation. Her physical status was New York Heart Association (NYHA) functional class II, and her oxygen saturation was 80% in room air. She reported no symptoms for the abdominal tumor preoperatively. The surgery was performed under general and epidural anesthesia. After induction of general anesthesia, she developed hypertension and tachycardia, and the manipulation of the tumor worsened them. Landiolol, a short acting beta blocker, and nicardipine were administrated.
2.[Usefullness of Beta-blocker for Hemodynamic Changes Induced by Uterotonic Drug in a Patient with Hypertrophic Obstructive Cardiomyopathy Undergoing Elective Cesarean Section].
Tsukano Y, Sugita M, Ikuta Y, Yamamoto T. Masui. 2015 Jun;64(6):642-6.
Combined spinal-epidural anesthesia (CSEA) was given to a 27-year-old woman with hypertrophic obstructive cardiomyopathy (HOCM) for a selective cesarean section. After the injection of uterotonic drug via uterine muscle and a vein after delivery, the patient developed dyspnea, tachycardia, ST-change on elecrocardiogram and hypotension. It is important in HOCM patients to control heart rate and left ventricular contractile force. We started to infuse beta-blocker (landiolol, 10 μg x kg(-1) x min(-1)) and improved these symptoms of the patient. This case demonstrates that CSEA is safe for HOCM patients and beta-blocker is effective to improve hemodynamic changes induced by uterotonic drug in these patients.
3.Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients.
Shibata SC1, Uchiyama A2, Ohta N2, Fujino Y2. J Cardiothorac Vasc Anesth. 2016 Apr;30(2):418-22. doi: 10.1053/j.jvca.2015.09.007. Epub 2015 Sep 25.
OBJECTIVE: The authors assessed the efficacy and safety of landiolol, an ultra-short-acting beta-blocker, with those of amiodarone in the restoration of sinus rhythm for postoperative atrial fibrillation (POAF) in intensive care unit (ICU) patients.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 63590-64-7 Terazosin

Terazosin
(CAS: 63590-64-7)

Terazosin, works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls, is a selective alpha1-antagonist used for trea...

CAS 147568-66-9 Carmoterol

Carmoterol
(CAS: 147568-66-9)

Carmoterol, a quinolin derivative, has been found to a β2-adrenoceptor agonist that could be an effective bronchodilating agent.

Nolomirole hydrochloride
(CAS: 138531-51-8)

Nolomirole is a Alpha 2 adrenergic receptor and Dopamine D2 receptor agonist. Nolomirole can attenuate the heart failure signs in the monocrotaline-induced cong...

CAS 61-76-7 Phenylephrine HCl

Phenylephrine HCl
(CAS: 61-76-7)

Phenylephrine HCl is a selective α1-adrenergic receptor agonist of the phenethylamine class used primarily as a decongestant, as an agent to dilate the pupil, a...

CAS 226081-74-9 AR-​08

AR-​08
(CAS: 226081-74-9)

AR-​08 is an agonist of α2-adrenergic receptor undergone in phase II clinical trials by Arbor Pharmaceuticals for the treatment of attention deficit and hyperac...

CAS 86347-15-1 Medetomidine HCl

Medetomidine HCl
(CAS: 86347-15-1)

Medetomidine is a selective α2-adrenoceptor agonist, with Ki of 1.08 nM, exhibts 1620-fold selectivity over α1-adrenoceptor.

CAS 72956-09-3 Carvedilol

Carvedilol
(CAS: 72956-09-3)

Carvedilol is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation.

GYKI-16084
(CAS: 185739-21-3)

GYKI-16084 is a postsynaptic alpha2-blocker with the potential to treat benign prostatic hyperplasia.

Chemical Structure

CAS 133242-30-5 Landiolol

Quick Inquiry

Verification code

Featured Items